Yonsei Med J.  2008 Jun;49(3):409-415. 10.3349/ymj.2008.49.3.409.

Changes in Treatment Outcomes of Gastric Cancer Surgery Over 45 Years at A Single Institution

• Hyung WJ
• Kim SS
• Choi WH
• Cheong JH
• Choi SH
• Kim CB
• Noh SH

• KMID: 724256
• DOI: http://doi.org/10.3349/ymj.2008.49.3.409

Abstract

PURPOSE
Although many studies have demonstrated improvements in short-and long-term outcomes of gastric cancer surgery, changes in long-term survival over time are not well-established. This study was conducted to evaluate changes in host, tumor, and treatment factors in patients treated at a single institution over a period of 45-yr. PATIENTS AND METHODS: We retrospectively evaluated 9282 patients with gastric cancer from 1955 to 1999, and divided the 45-yr into 4 time frames based on published articles: 1955 to 1962 (n=228), 1963 to 1972 (n=891), 1973 to 1988 (n=2789), and 1989 to 1999 (n=5374). RESULTS: Remarkable changes were noted in host, tumor, treatment factors, and prognosis. Among host factors, patients of more advanced age were identified in the 4th period and mean age shifted from 49 to 55 yrs. Among tumor factors, early gastric cancers and upper body tumors increased up to 32% and from 7% to 13%, respectively. An increase in the annual number of patients (from 29 to 649), gastrectomies (from 14 to 600), rate of resection (from 50% to 90%), rate of curative resection (up to 92%), and proportion of total gastrectomy (from 8% to 29%) was noted. Operative mortality was reduced from 6.1% to 0.7%. The overall 5-yr survival rate significantly increased from 22% to 65%. CONCLUSION: Treatment results of gastric cancer surgery have improved remarkably over the 45-year period. Increase of early stage gastric cancer with early diagnosis considerably influenced the improved survival of patients with gastric cancer.

Keyword

Gastric cancer; surgery; treatment results

MeSH Terms

Age Distribution
Aged
Aged, 80 and over
Female
Gastrectomy/adverse effects/*methods/statistics & numerical data
Humans
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Sex Distribution
Stomach Neoplasms/mortality/pathology/*surgery
Survival Analysis
Survival Rate
Treatment Outcome

Figure

• 

  Fig. 1 Annual number of gastrectomies for gastric cancer from 1955 to 1999.

Reference

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005. 241:27–39.

2. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004. 240:808–816.

3. Noh SH, Hyung WJ, Cheong JH. Minimally invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol. 2005. 90:188–193.

4. Suh KW, Kim CB, Kim MW, Chi HS, Cho CH, Kim BR, et al. A clinical study of 2789 gastric cancers. J Korean Surg Soc. 1991. 41:148–158.

5. Suh SH, Kim CK, Whang KC. Clinical observation of stomach cancer in Korea. J Korean Surg Soc. 1964. 6:1–14.

6. Suh SH, Whang HS, Kim CK, Whang KC. Five-year survival rate after gastric resection in carcinoma of the stomach. J Korean Surg Soc. 1964. 6:15–20.

7. Whang KC. Five year survival rate of the stomach cancer in Korea. J Korean Surg Soc. 1975. 17:975–982.

8. Whang KC, Min JS, Yoon SO, Min KS. Stomach cancer in Korea. J Korean Surg Soc. 1975. 17:477–502.

9. American Joint Committee for Cancer Staging and End-Results Reporting. Manual for staging of cancer. 1977. Chicago: American Joint Committee.

10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958. 53:457–481.

11. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 2002. 6th ed. New York: Springer-Verlag.

12. Yoo CH, Noh SH, Kim YI, Min JS. Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. International Union Against Cancer. World J Surg. 1999. 23:492–497. discussion 497-8.

13. Korean Gastric Cancer Association. Nationwide gastric cancer report in Korea. J Korean Gastric Cancer Assoc. 2002. 2:105–114.

14. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002. 5:177–182.

15. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995. 345:745–748.

16. Piso P, Werner U, Lang H, Mirena P, Klempnauer J. Proximal versus distal gastric carcinoma--what are the differences? Ann Surg Oncol. 2000. 7:520–525.

17. Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg. 1997. 225:678–683. discussion 683-5.

18. Pacelli F, Papa V, Caprino P, Sgadari A, Bossola M, Doglietto GB. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg. 2001. 67:697–703.

19. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/ topographic classification in 1,002 consecutive patients. Ann Surg. 2000. 232:353–361.

20. Stein HJ, Feith M, Siewert JR. Individualized surgical strategies for cancer of the esophagogastric junction. Ann Chir Gynaecol. 2000. 89:191–198.

21. Dimick JB, Cowan JA Jr, Stanley JC, Henke PK, Pronovost PJ, Upchurch GR Jr. Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg. 2003. 38:739–744.

22. Bentrem DJ, Brennan MF. Outcomes in oncologic surgery: does volume make a difference? World J Surg. 2005. 29:1210–1216.

23. Bachmann MO, Alderson D, Edwards D, Wotton S, Bedford C, Peters TJ, et al. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg. 2002. 89:914–922.

24. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg. 2004. 91:610–617.

25. Golledge J, Wiggins JE, Callam MJ. Effect of surgical subspecialization on breast cancer outcome. Br J Surg. 2000. 87:1420–1425.

26. Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000. 83:986–991.

27. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer. 2000. 36:390–396.

28. Kitamura K, Yamaguchi T, Sawai K, Nishida S, Yamamoto K, Okamoto K, et al. Chronologic changes in the clinicopathologic findings and survival of gastric cancer patients. J Clin Oncol. 1997. 15:3471–3480.

29. Lee WJ, Lee WC, Houng SJ, Shun CT, Houng RL, Lee PH, et al. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg. 1995. 19:707–713.

30. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer. 1995. 76:1302–1312.

31. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998. 228:449–461.

32. Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Müller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 1996. 83:1144–1147.